You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The FDA center of excellence has engaged the technology vendor to incorporate real-world evidence into regulatory decision-making for precision oncology treatments.
The new center will focus on supporting and mentoring junior faculty researchers as well as on building bioinformatics infrastructure for projects.
The new center will help accelerate personalized medicine efforts and support a collaborative research ecosystem in Europe.
The single-cell genomics center at the Monash Health Translation Precinct near Melbourne will be the first of its kind in Australia.
As one of 33 Roche MCOEs in the US, Diagnostic Service Laboratories will offer the company's molecular technologies including the cobas CT/NG v.2.0 test.
NIAID plans to eventually establish five centers that provide high-performance compute, tools, and training to researchers in Africa.
WCC will help develop standards of care and best practices for integrating molecular profiling into cancer care.
The Caris Centers of Excellence for Precision Medicine Network will establish tumor profiling standards and provide access to Caris' database of patient outcomes.
NEW YORK (GenomeWeb) — RainDance Technologies said today that the HudsonAlpha Institute for Biotechnology is now a RainDance Center of Excellence.
NEW YORK (GenomeWeb) — RUCDR Infinite Biologics, the research services and biorepository arm of the Rutgers University Cell and DNA Repository (RUCDR), has been named a RainDance Technologies Center of Excellence, the partners said this week.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.